|   News

Accent Therapeutics reels in $40M to target RNA-modifying proteins in cancer


Accent Therapeutics launched Friday with $40 million in the bank to develop cancer treatments based on epistranscriptomics, or the science around RNA structure, stability, function and translation in cell biology.

Read more.